Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.
This report aims to provide a comprehensive presentation of the global market for Pneumonia Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumonia Vaccine. This report contains market size and forecasts of Pneumonia Vaccine in global, including the following market information:
Global Pneumonia Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pneumonia Vaccine Market Sales, 2018-2023, 2024-2029, (K Doses)
Global top five Pneumonia Vaccine companies in 2022 (%)
The global Pneumonia Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Pneumococcal Conjugate Vaccine (PCV13) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pneumonia Vaccine include Pfizer Inc., Glaxosmithkline Plc., Merck & Co., Inc., Sanofi Pasteur, Serum Institute of India Pvt. Ltd., Johnson & Johnson, Astellas Pharma Inc., Astrazeneca Plc. and CSL Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pneumonia Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pneumonia Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Pneumonia Vaccine Market Segment Percentages, by Type, 2022 (%)
- Pneumococcal Conjugate Vaccine (PCV13)
- Pneumococcal Polysaccharide Vaccine (PPSV23)
- Other
Global Pneumonia Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Pneumonia Vaccine Market Segment Percentages, by Application, 2022 (%)
- Pneumonia
- Meningitis
- Sepsis
Global Pneumonia Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Pneumonia Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pneumonia Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pneumonia Vaccine revenues share in global market, 2022 (%)
Key companies Pneumonia Vaccine sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Pneumonia Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer Inc.
- Glaxosmithkline Plc.
- Merck & Co., Inc.
- Sanofi Pasteur
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson
- Astellas Pharma Inc.
- Astrazeneca Plc.
- CSL Limited
- Emergent Biosolutions
- Walvax Biotechnology
- Royal (Wuxi) Bio-Pharmaceutical
- Zhifei Biologic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pneumonia Vaccine, market overview.
Chapter 2: Global Pneumonia Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Pneumonia Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pneumonia Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pneumonia Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Pneumonia Vaccine Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Pneumonia Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pneumonia Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pneumonia Vaccine Overall Market Size
2.1 Global Pneumonia Vaccine Market Size: 2022 VS 2029
2.2 Global Pneumonia Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pneumonia Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Pneumonia Vaccine Players in Global Market
3.2 Top Global Pneumonia Vaccine Companies Ranked by Revenue
3.3 Global Pneumonia Vaccine Revenue by Companies
3.4 Global Pneumonia Vaccine Sales by Companies
3.5 Global Pneumonia Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pneumonia Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pneumonia Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pneumonia Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Pneumonia Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Pneumonia Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pneumonia Vaccine Market Size Markets, 2022 & 2029
4.1.2 Pneumococcal Conjugate Vaccine (PCV13)
4.1.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
4.1.4 Other
4.2 By Type - Global Pneumonia Vaccine Revenue & Forecasts
4.2.1 By Type - Global Pneumonia Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Pneumonia Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Pneumonia Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Pneumonia Vaccine Sales & Forecasts
4.3.1 By Type - Global Pneumonia Vaccine Sales, 2018-2023
4.3.2 By Type - Global Pneumonia Vaccine Sales, 2024-2029
4.3.3 By Type - Global Pneumonia Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Pneumonia Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pneumonia Vaccine Market Size, 2022 & 2029
5.1.2 Pneumonia
5.1.3 Meningitis
5.1.4 Sepsis
5.2 By Application - Global Pneumonia Vaccine Revenue & Forecasts
5.2.1 By Application - Global Pneumonia Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Pneumonia Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Pneumonia Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Pneumonia Vaccine Sales & Forecasts
5.3.1 By Application - Global Pneumonia Vaccine Sales, 2018-2023
5.3.2 By Application - Global Pneumonia Vaccine Sales, 2024-2029
5.3.3 By Application - Global Pneumonia Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Pneumonia Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Pneumonia Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Pneumonia Vaccine Revenue & Forecasts
6.2.1 By Region - Global Pneumonia Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Pneumonia Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Pneumonia Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Pneumonia Vaccine Sales & Forecasts
6.3.1 By Region - Global Pneumonia Vaccine Sales, 2018-2023
6.3.2 By Region - Global Pneumonia Vaccine Sales, 2024-2029
6.3.3 By Region - Global Pneumonia Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Pneumonia Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Pneumonia Vaccine Sales, 2018-2029
6.4.3 US Pneumonia Vaccine Market Size, 2018-2029
6.4.4 Canada Pneumonia Vaccine Market Size, 2018-2029
6.4.5 Mexico Pneumonia Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Pneumonia Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Pneumonia Vaccine Sales, 2018-2029
6.5.3 Germany Pneumonia Vaccine Market Size, 2018-2029
6.5.4 France Pneumonia Vaccine Market Size, 2018-2029
6.5.5 U.K. Pneumonia Vaccine Market Size, 2018-2029
6.5.6 Italy Pneumonia Vaccine Market Size, 2018-2029
6.5.7 Russia Pneumonia Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Pneumonia Vaccine Market Size, 2018-2029
6.5.9 Benelux Pneumonia Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Pneumonia Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Pneumonia Vaccine Sales, 2018-2029
6.6.3 China Pneumonia Vaccine Market Size, 2018-2029
6.6.4 Japan Pneumonia Vaccine Market Size, 2018-2029
6.6.5 South Korea Pneumonia Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Pneumonia Vaccine Market Size, 2018-2029
6.6.7 India Pneumonia Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Pneumonia Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Pneumonia Vaccine Sales, 2018-2029
6.7.3 Brazil Pneumonia Vaccine Market Size, 2018-2029
6.7.4 Argentina Pneumonia Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pneumonia Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Pneumonia Vaccine Sales, 2018-2029
6.8.3 Turkey Pneumonia Vaccine Market Size, 2018-2029
6.8.4 Israel Pneumonia Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Pneumonia Vaccine Market Size, 2018-2029
6.8.6 UAE Pneumonia Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Pneumonia Vaccine Major Product Offerings
7.1.4 Pfizer Inc. Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Glaxosmithkline Plc.
7.2.1 Glaxosmithkline Plc. Company Summary
7.2.2 Glaxosmithkline Plc. Business Overview
7.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Major Product Offerings
7.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Glaxosmithkline Plc. Key News & Latest Developments
7.3 Merck & Co., Inc.
7.3.1 Merck & Co., Inc. Company Summary
7.3.2 Merck & Co., Inc. Business Overview
7.3.3 Merck & Co., Inc. Pneumonia Vaccine Major Product Offerings
7.3.4 Merck & Co., Inc. Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Merck & Co., Inc. Key News & Latest Developments
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Company Summary
7.4.2 Sanofi Pasteur Business Overview
7.4.3 Sanofi Pasteur Pneumonia Vaccine Major Product Offerings
7.4.4 Sanofi Pasteur Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Pasteur Key News & Latest Developments
7.5 Serum Institute of India Pvt. Ltd.
7.5.1 Serum Institute of India Pvt. Ltd. Company Summary
7.5.2 Serum Institute of India Pvt. Ltd. Business Overview
7.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Major Product Offerings
7.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Serum Institute of India Pvt. Ltd. Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Pneumonia Vaccine Major Product Offerings
7.6.4 Johnson & Johnson Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Astellas Pharma Inc.
7.7.1 Astellas Pharma Inc. Company Summary
7.7.2 Astellas Pharma Inc. Business Overview
7.7.3 Astellas Pharma Inc. Pneumonia Vaccine Major Product Offerings
7.7.4 Astellas Pharma Inc. Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Astellas Pharma Inc. Key News & Latest Developments
7.8 Astrazeneca Plc.
7.8.1 Astrazeneca Plc. Company Summary
7.8.2 Astrazeneca Plc. Business Overview
7.8.3 Astrazeneca Plc. Pneumonia Vaccine Major Product Offerings
7.8.4 Astrazeneca Plc. Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Astrazeneca Plc. Key News & Latest Developments
7.9 CSL Limited
7.9.1 CSL Limited Company Summary
7.9.2 CSL Limited Business Overview
7.9.3 CSL Limited Pneumonia Vaccine Major Product Offerings
7.9.4 CSL Limited Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 CSL Limited Key News & Latest Developments
7.10 Emergent Biosolutions
7.10.1 Emergent Biosolutions Company Summary
7.10.2 Emergent Biosolutions Business Overview
7.10.3 Emergent Biosolutions Pneumonia Vaccine Major Product Offerings
7.10.4 Emergent Biosolutions Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Emergent Biosolutions Key News & Latest Developments
7.11 Walvax Biotechnology
7.11.1 Walvax Biotechnology Company Summary
7.11.2 Walvax Biotechnology Pneumonia Vaccine Business Overview
7.11.3 Walvax Biotechnology Pneumonia Vaccine Major Product Offerings
7.11.4 Walvax Biotechnology Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Walvax Biotechnology Key News & Latest Developments
7.12 Royal (Wuxi) Bio-Pharmaceutical
7.12.1 Royal (Wuxi) Bio-Pharmaceutical Company Summary
7.12.2 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Business Overview
7.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Major Product Offerings
7.12.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Royal (Wuxi) Bio-Pharmaceutical Key News & Latest Developments
7.13 Zhifei Biologic
7.13.1 Zhifei Biologic Company Summary
7.13.2 Zhifei Biologic Pneumonia Vaccine Business Overview
7.13.3 Zhifei Biologic Pneumonia Vaccine Major Product Offerings
7.13.4 Zhifei Biologic Pneumonia Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Zhifei Biologic Key News & Latest Developments
8 Global Pneumonia Vaccine Production Capacity, Analysis
8.1 Global Pneumonia Vaccine Production Capacity, 2018-2029
8.2 Pneumonia Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Pneumonia Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pneumonia Vaccine Supply Chain Analysis
10.1 Pneumonia Vaccine Industry Value Chain
10.2 Pneumonia Vaccine Upstream Market
10.3 Pneumonia Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pneumonia Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Pneumonia Vaccine in Global Market
Table 2. Top Pneumonia Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Pneumonia Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Pneumonia Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Pneumonia Vaccine Sales by Companies, (K Doses), 2018-2023
Table 6. Global Pneumonia Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Pneumonia Vaccine Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Pneumonia Vaccine Product Type
Table 9. List of Global Tier 1 Pneumonia Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pneumonia Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Pneumonia Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Pneumonia Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Pneumonia Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Pneumonia Vaccine Sales (K Doses), 2018-2023
Table 15. By Type - Global Pneumonia Vaccine Sales (K Doses), 2024-2029
Table 16. By Application - Global Pneumonia Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Pneumonia Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Pneumonia Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Pneumonia Vaccine Sales (K Doses), 2018-2023
Table 20. By Application - Global Pneumonia Vaccine Sales (K Doses), 2024-2029
Table 21. By Region - Global Pneumonia Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Pneumonia Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Pneumonia Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Pneumonia Vaccine Sales (K Doses), 2018-2023
Table 25. By Region - Global Pneumonia Vaccine Sales (K Doses), 2024-2029
Table 26. By Country - North America Pneumonia Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Pneumonia Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Pneumonia Vaccine Sales, (K Doses), 2018-2023
Table 29. By Country - North America Pneumonia Vaccine Sales, (K Doses), 2024-2029
Table 30. By Country - Europe Pneumonia Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Pneumonia Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Pneumonia Vaccine Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Pneumonia Vaccine Sales, (K Doses), 2024-2029
Table 34. By Region - Asia Pneumonia Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Pneumonia Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Pneumonia Vaccine Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Pneumonia Vaccine Sales, (K Doses), 2024-2029
Table 38. By Country - South America Pneumonia Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Pneumonia Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Pneumonia Vaccine Sales, (K Doses), 2018-2023
Table 41. By Country - South America Pneumonia Vaccine Sales, (K Doses), 2024-2029
Table 42. By Country - Middle East & Africa Pneumonia Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Pneumonia Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Pneumonia Vaccine Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Pneumonia Vaccine Sales, (K Doses), 2024-2029
Table 46. Pfizer Inc. Company Summary
Table 47. Pfizer Inc. Pneumonia Vaccine Product Offerings
Table 48. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. Pfizer Inc. Key News & Latest Developments
Table 50. Glaxosmithkline Plc. Company Summary
Table 51. Glaxosmithkline Plc. Pneumonia Vaccine Product Offerings
Table 52. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Glaxosmithkline Plc. Key News & Latest Developments
Table 54. Merck & Co., Inc. Company Summary
Table 55. Merck & Co., Inc. Pneumonia Vaccine Product Offerings
Table 56. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Merck & Co., Inc. Key News & Latest Developments
Table 58. Sanofi Pasteur Company Summary
Table 59. Sanofi Pasteur Pneumonia Vaccine Product Offerings
Table 60. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. Sanofi Pasteur Key News & Latest Developments
Table 62. Serum Institute of India Pvt. Ltd. Company Summary
Table 63. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Offerings
Table 64. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Serum Institute of India Pvt. Ltd. Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Pneumonia Vaccine Product Offerings
Table 68. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Astellas Pharma Inc. Company Summary
Table 71. Astellas Pharma Inc. Pneumonia Vaccine Product Offerings
Table 72. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. Astellas Pharma Inc. Key News & Latest Developments
Table 74. Astrazeneca Plc. Company Summary
Table 75. Astrazeneca Plc. Pneumonia Vaccine Product Offerings
Table 76. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Astrazeneca Plc. Key News & Latest Developments
Table 78. CSL Limited Company Summary
Table 79. CSL Limited Pneumonia Vaccine Product Offerings
Table 80. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. CSL Limited Key News & Latest Developments
Table 82. Emergent Biosolutions Company Summary
Table 83. Emergent Biosolutions Pneumonia Vaccine Product Offerings
Table 84. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. Emergent Biosolutions Key News & Latest Developments
Table 86. Walvax Biotechnology Company Summary
Table 87. Walvax Biotechnology Pneumonia Vaccine Product Offerings
Table 88. Walvax Biotechnology Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 89. Walvax Biotechnology Key News & Latest Developments
Table 90. Royal (Wuxi) Bio-Pharmaceutical Company Summary
Table 91. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Offerings
Table 92. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 93. Royal (Wuxi) Bio-Pharmaceutical Key News & Latest Developments
Table 94. Zhifei Biologic Company Summary
Table 95. Zhifei Biologic Pneumonia Vaccine Product Offerings
Table 96. Zhifei Biologic Pneumonia Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 97. Zhifei Biologic Key News & Latest Developments
Table 98. Pneumonia Vaccine Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 99. Global Pneumonia Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Pneumonia Vaccine Production by Region, 2018-2023 (K Doses)
Table 101. Global Pneumonia Vaccine Production by Region, 2024-2029 (K Doses)
Table 102. Pneumonia Vaccine Market Opportunities & Trends in Global Market
Table 103. Pneumonia Vaccine Market Drivers in Global Market
Table 104. Pneumonia Vaccine Market Restraints in Global Market
Table 105. Pneumonia Vaccine Raw Materials
Table 106. Pneumonia Vaccine Raw Materials Suppliers in Global Market
Table 107. Typical Pneumonia Vaccine Downstream
Table 108. Pneumonia Vaccine Downstream Clients in Global Market
Table 109. Pneumonia Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pneumonia Vaccine Segment by Type in 2022
Figure 2. Pneumonia Vaccine Segment by Application in 2022
Figure 3. Global Pneumonia Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pneumonia Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pneumonia Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Pneumonia Vaccine Sales in Global Market: 2018-2029 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Pneumonia Vaccine Revenue in 2022
Figure 9. By Type - Global Pneumonia Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Pneumonia Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Pneumonia Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Pneumonia Vaccine Price (USD/Dose), 2018-2029
Figure 13. By Application - Global Pneumonia Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Pneumonia Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Pneumonia Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Pneumonia Vaccine Price (USD/Dose), 2018-2029
Figure 17. By Region - Global Pneumonia Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Pneumonia Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Pneumonia Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Pneumonia Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Pneumonia Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Pneumonia Vaccine Sales Market Share, 2018-2029
Figure 23. US Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Pneumonia Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Pneumonia Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Pneumonia Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Pneumonia Vaccine Sales Market Share, 2018-2029
Figure 37. China Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Pneumonia Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Pneumonia Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Pneumonia Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Pneumonia Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Pneumonia Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Pneumonia Vaccine Production Capacity (K Doses), 2018-2029
Figure 53. The Percentage of Production Pneumonia Vaccine by Region, 2022 VS 2029
Figure 54. Pneumonia Vaccine Industry Value Chain
Figure 55. Marketing Channels
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
